Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study.
Dang H, van Pelt GW, Haasnoot KJC, Backes Y, Elias SG, Seerden TCJ, Schwartz MP, Spanier BWM, de Vos Tot Nederveen Cappel WH, van Bergeijk JD, Kessels K, Geesing JMJ, Groen JN, Borg FT, Wolfhagen FHJ, Seldenrijk CA, Raicu MG, Milne AN, van Lent AUG, Brosens LAA, Johan A Offerhaus G, Siersema PD, Tollenaar RAEM, Hardwick JCH, Hawinkels LJAC, Moons LMG, Lacle MM, Mesker WE, Boonstra JJ; Dutch T1 CRC Working Group. Dang H, et al. Among authors: siersema pd. United European Gastroenterol J. 2021 Feb 10. doi: 10.1177/2050640620975324. Online ahead of print. United European Gastroenterol J. 2021. PMID: 33566452 Free article.
The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Among authors: siersema pd. J Clin Pathol. 2004 Oct;57(10):1063-8. doi: 10.1136/jcp.2003.015727. J Clin Pathol. 2004. PMID: 15452161 Free PMC article.
COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Among authors: siersema pd. Am J Gastroenterol. 2007 Nov;102(11):2373-9. doi: 10.1111/j.1572-0241.2007.01373.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581270
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.
Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD; Dutch SUSTENT Study Group. Jeurnink SM, et al. Among authors: siersema pd. Gastrointest Endosc. 2010 Mar;71(3):490-9. doi: 10.1016/j.gie.2009.09.042. Epub 2009 Dec 8. Gastrointest Endosc. 2010. PMID: 20003966 Clinical Trial.
Predictors of survival in patients with malignant gastric outlet obstruction: a patient-oriented decision approach for palliative treatment.
Jeurnink SM, Steyerberg EW, Vleggaar FP, van Eijck CH, van Hooft JE, Schwartz MP, Kuipers EJ, Siersema PD; Dutch SUSTENT Study Group. Jeurnink SM, et al. Among authors: siersema pd. Dig Liver Dis. 2011 Jul;43(7):548-52. doi: 10.1016/j.dld.2011.01.017. Epub 2011 Mar 4. Dig Liver Dis. 2011. PMID: 21376680 Clinical Trial.
Protein energy malnutrition predicts complications in liver cirrhosis.
Huisman EJ, Trip EJ, Siersema PD, van Hoek B, van Erpecum KJ. Huisman EJ, et al. Among authors: siersema pd. Eur J Gastroenterol Hepatol. 2011 Nov;23(11):982-9. doi: 10.1097/MEG.0b013e32834aa4bb. Eur J Gastroenterol Hepatol. 2011. PMID: 21971339
790 results